Your session is about to expire
← Back to Search
SEL + Equity for Domestic Violence (R-CITY Trial)
N/A
Recruiting
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
- General education teachers of core subjects (Mathematics, Science, Social Studies, English/Language Arts)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, within one month following the completion of the intervention.
Awards & highlights
R-CITY Trial Summary
This trial uses 4 "Rs" to create a safe & positive learning environment for all: Recognizing, Responding, Restoring Relationships & Resilience. It aims to build equity stamina & enhance SEL skills.
Who is the study for?
The R-CITY Project is for general education teachers of core subjects like Math, Science, Social Studies, and English in Anne Arundel County Public Schools. It aims to enhance their ability to create a positive learning environment by integrating equity literacy with social and emotional learning (SEL).Check my eligibility
What is being tested?
This study compares two educational approaches: 'SEL + Equity', which combines SEL curriculum with equity lessons, versus 'SEL Only', the standard SEL program. The goal is to see if adding equity training improves school environments.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no traditional side effects. However, participants may experience challenges adapting new teaching methods or changes in classroom dynamics.
R-CITY Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowR-CITY Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention, within one month following the completion of the intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, within one month following the completion of the intervention.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ASSIST Classroom Observations
Secondary outcome measures
R-CITY Teacher Self-Report Survey
Suspensions
R-CITY Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SEL + EquityExperimental Treatment1 Intervention
SEL + Equity (Second Step + Equity) supports include supports from the SEL Only condition plus:
Training and implementation support for teachers to deliver 6 equity literacy lessons tailored to each grade level (4th and 5th for elementary schools; 6th - 8th for middle schools) and aligned with Second Step core content
Five 45-minute school-wide equity focused Professional Development (PD) sessions to complement AACPS Equity PD
Individualized teacher coaching to support implementing equity practices and equity-focused classroom lessons
Group II: SEL OnlyActive Control1 Intervention
SEL Only Condition supports include:
School wide support for implementation of Second Step curriculum (e.g., technical assistance professional development, facilitated professional learning communities)
Support to Positive Behavioral Intervention and Supports (PBIS) and Multi Tiered System of Supports (MTSS) and equity teams with alignment of initiatives
Individualized technical assistance with Second Step SEL implementation
Find a Location
Who is running the clinical trial?
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,215,891 Total Patients Enrolled
Sheppard Pratt Health SystemOTHER
21 Previous Clinical Trials
7,489 Total Patients Enrolled
University of VirginiaLead Sponsor
754 Previous Clinical Trials
1,244,753 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: SEL Only
- Group 2: SEL + Equity
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruiting for this trial ongoing?
"Per the information posted on clinicaltrials.gov, recruitment for this trial is currently ongoing and began in September 2021. This study was last edited on October 18th 2022."
Answered by AI
What is the aggregate amount of participants enrolled in this experiment?
"Affirmative. The clinical trial database shows that, as of October 18th 2022, this medical study is still recruiting participants to reach a total target number of 320 patients from 1 location. It was initially posted on September 15th 2021."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger